Children’s Oncology Group (COG) trials for retinoblastoma Book Section


Authors: Gombos, D. S.; Meadows, A. T.; Chintagumpala, M.; Dunkel, I. J.; Friedman, D.; Stoner, J. A.; Jubran, R.; Villablanca, J. G.
Editors: Singh, A. S.; Murphree, A. L.; Damato, B. E.
Article/Chapter Title: Children’s Oncology Group (COG) trials for retinoblastoma
Abstract: For the past 30 years, retinoblastoma, a tumor that occurs in only 3 % of children with cancer, has been the subject of extensive molecular biologic research. However, apart from a short period in the 1970s, retinoblastoma has not been studied by any of the pediatric cooperative groups. The past decade has witnessed significant multidisciplinary prospective clinical and biologic studies of this rare pediatric neoplasm. The Children’s Oncology Group (COG) has successfully opened four clinical trials with a fifth recently approved. This chapter will review these ongoing prospective multicenter trials. © Springer-Verlag Berlin Heidelberg 2015. All rights reserved.
Book Title: Clinical Ophthalmic Oncology: Retinoblastoma. 2nd ed
ISBN: 978-3-662-43450-5
Publisher: Springer Berlin Heidelberg  
Publication Place: Berlin, Germany
Date Published: 2015-01-01
Start Page: 215
End Page: 223
Language: English
DOI: 10.1007/978-3-662-43451-2_21
PROVIDER: scopus
DOI/URL:
Notes: Book Chapter: 21 -- Export Date: 3 March 2016 -- Source: Scopus
Altmetric
Citation Impact
MSK Authors
  1. Ira J Dunkel
    354 Dunkel